State Street’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-196,179
| Closed | -$957K | – | 4266 |
|
|
2025
Q1 | $957K | Sell |
196,179
-1,742
| -0.9% | -$10.5K | ﹤0.01% | 3436 |
|
|
2024
Q4 | $1.65M | Buy |
197,921
+5,825
| +3% | +$50.9K | ﹤0.01% | 3379 |
|
|
2024
Q3 | $2M | Buy |
192,096
+2,169
| +1% | +$36.1K | ﹤0.01% | 3330 |
|
|
2024
Q2 | $3.74M | Buy |
189,927
+18,520
| +11% | +$371K | ﹤0.01% | 3056 |
|
|
2024
Q1 | $4.39M | Sell |
171,407
-521,879
| -75% | -$13.4M | ﹤0.01% | 2981 |
|
|
2023
Q4 | $19.1M | Buy |
693,286
+60,030
| +9% | +$3.66M | ﹤0.01% | 2239 |
|
|
2023
Q3 | $38.5M | Sell |
633,256
-184,651
| -23% | -$13M | ﹤0.01% | 1784 |
|
|
2023
Q2 | $53.8M | Sell |
817,907
-70,370
| -8% | -$5.15M | ﹤0.01% | 1627 |
|
|
2023
Q1 | $56.5M | Buy |
888,277
+250,303
| +39% | +$28.6M | ﹤0.01% | 1572 |
|
|
2022
Q4 | $88.3M | Buy |
637,974
+1,950
| +0.3% | +$275K | 0.01% | 1241 |
|
|
2022
Q3 | $80.5M | Buy |
636,024
+544,769
| +597% | +$61.6M | 0.01% | 1260 |
|
|
2022
Q2 | $7.56M | Sell |
91,255
-566,340
| -86% | -$43.9M | ﹤0.01% | 2877 |
|
|
2022
Q1 | $63.8M | Buy |
657,595
+276,729
| +73% | +$36.5M | ﹤0.01% | 1605 |
|
|
2021
Q4 | $76.1M | Buy |
380,866
+35,787
| +10% | +$8.44M | ﹤0.01% | 1517 |
|
|
2021
Q3 | $85.4M | Buy |
345,079
+133,500
| +63% | +$38.2M | ﹤0.01% | 1403 |
|
|
2021
Q2 | $87.6M | Buy |
211,579
+24,620
| +13% | +$9.75M | ﹤0.01% | 1405 |
|
|
2021
Q1 | $73M | Buy |
186,959
+10,104
| +6% | +$4.98M | ﹤0.01% | 1470 |
|
|
2020
Q4 | $99.1M | Buy |
176,855
+43,884
| +33% | +$27.8M | 0.01% | 1149 |
|
|
2020
Q3 | $92.9M | Buy |
132,971
+6,171
| +5% | +$4.81M | 0.01% | 1012 |
|
|
2020
Q2 | $100M | Buy |
126,800
+7,760
| +7% | +$5.85M | 0.01% | 956 |
|
|
2020
Q1 | $70.9M | Buy |
119,040
+1,601
| +1% | +$1.56M | 0.01% | 1037 |
|
|
2019
Q4 | $133M | Buy |
117,439
+16,752
| +17% | +$18.2M | 0.01% | 872 |
|
|
2019
Q3 | $120M | Buy |
100,687
+10,095
| +11% | +$15.4M | 0.01% | 895 |
|
|
2019
Q2 | $149M | Buy |
90,592
+867
| +1% | +$1.5M | 0.01% | 806 |
|
|
2019
Q1 | $183M | Buy |
89,725
+182
| +0.2% | +$320K | 0.01% | 703 |
|
|
2018
Q4 | $115M | Buy |
89,543
+4,007
| +5% | +$6.15M | 0.01% | 828 |
|
|
2018
Q3 | $162M | Buy |
85,536
+10,192
| +14% | +$21.1M | 0.01% | 792 |
|
|
2018
Q2 | $153M | Sell |
75,344
-22,235
| -23% | -$50.7M | 0.01% | 799 |
|
|
2018
Q1 | $216M | Sell |
97,579
-4,445
| -4% | -$11.3M | 0.02% | 662 |
|
|
2017
Q4 | $235M | Sell |
102,024
-13,014
| -11% | -$26.4M | 0.02% | 629 |
|
|
2017
Q3 | $205M | Buy |
115,038
+2,628
| +2% | +$3.67M | 0.02% | 657 |
|
|
2017
Q2 | $153M | Sell |
112,410
-11,962
| -10% | -$14.4M | 0.01% | 751 |
|
|
2017
Q1 | $146M | Buy |
124,372
+4,496
| +4% | +$4.59M | 0.01% | 764 |
|
|
2016
Q4 | $95.8M | Sell |
119,876
-8,239
| -6% | -$6.54M | 0.01% | 930 |
|
|
2016
Q3 | $112M | Sell |
128,115
-3,123
| -2% | -$2.26M | 0.01% | 808 |
|
|
2016
Q2 | $73.6M | Buy |
131,238
+38,449
| +41% | +$21.8M | 0.01% | 983 |
|
|
2016
Q1 | $51.1M | Buy |
92,789
+19,088
| +26% | +$11.7M | 0.01% | 1157 |
|
|
2015
Q4 | $61.3M | Buy |
73,701
+26,073
| +55% | +$26M | 0.01% | 1065 |
|
|
2015
Q3 | $52.8M | Buy |
47,628
+11,380
| +31% | +$20.8M | 0.01% | 1127 |
|
|
2015
Q2 | $79.1M | Sell |
36,248
-9,660
| -21% | -$19.7M | 0.01% | 984 |
|
|
2015
Q1 | $71.8M | Buy |
45,908
+3,868
| +9% | +$5.1M | 0.01% | 1034 |
|
|
2014
Q4 | $49.9M | Sell |
42,040
-15,288
| -27% | -$10.2M | 0.01% | 1230 |
|
|
2014
Q3 | $26.6M | Buy |
57,328
+37,980
| +196% | +$17.5M | ﹤0.01% | 1531 |
|
|
2014
Q2 | $9.67M | Buy |
19,348
+12,378
| +178% | +$3.97M | ﹤0.01% | 2247 |
|
|
2014
Q1 | $2.05M | Buy |
6,970
+1,144
| +20% | +$347K | ﹤0.01% | 3049 |
|
|
2013
Q4 | $1.58M | Buy |
5,826
+1,438
| +33% | +$402K | ﹤0.01% | 3156 |
|
|
2013
Q3 | $1.53M | Buy |
+4,388
| New | +$1.63M | ﹤0.01% | 3144 |
|
Other funds holding BLUE
State Street's BLUE Position: Q2 2025 in Review
State Street sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 196,179 shares — an estimated $957K sold.
State Street first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $235M in Q4 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- State Street reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- State Street sold 196,179 bluebird bio shares in Q2 2025, an estimated $957K.
- State Street first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- State Street's bluebird bio position peaked at $235M in Q4 2017.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.